Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.23 EUR | +1.16% | +1.27% | +38.90% |
05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
05-03 | AIB buys back EUR999 million worth of shares from Irish government | AN |
Sales 2024 * | 4.56B 4.96B 6.77B | Sales 2025 * | 4.34B 4.72B 6.45B | Capitalization | 12.64B 13.75B 18.77B |
---|---|---|---|---|---|
Net income 2024 * | 1.76B 1.92B 2.62B | Net income 2025 * | 1.56B 1.7B 2.32B | EV / Sales 2024 * | 2.77 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 2.91 x |
P/E ratio 2024 * |
7.28
x | P/E ratio 2025 * |
7.57
x | Employees | - |
Yield 2024 * |
5.76% | Yield 2025 * |
6.1% | Free-Float | 68.01% |
Latest transcript on AIB Group plc
1 week | +1.27% | ||
1 month | +7.40% | ||
3 months | +21.02% | ||
6 months | +25.85% | ||
Current year | +38.90% |
Managers | Title | Age | Since |
---|---|---|---|
Colin Hunt
CEO | Chief Executive Officer | 54 | 15-12-31 |
Donal Galvin
DFI | Director of Finance/CFO | 50 | 13-08-31 |
Graham Fagan
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fergal O’Dwyer
BRD | Director/Board Member | 64 | 21-01-21 |
James Pettigrew
CHM | Chairman | 65 | 21-10-27 |
Basil Geoghegan
BRD | Director/Board Member | - | 19-09-03 |
Date | Price | Change |
---|---|---|
24-06-03 | 5.17 | 0.00% |
24-05-31 | 5.17 | +0.88% |
24-05-30 | 5.125 | +1.59% |
24-05-29 | 5.045 | -1.37% |
24-05-28 | 5.115 | -0.68% |
Delayed Quote Börse Stuttgart, June 03, 2024 at 02:14 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.23% | 582B | |
+17.12% | 313B | |
+17.02% | 251B | |
+19.12% | 209B | |
+20.86% | 180B | |
+25.17% | 169B | |
+9.10% | 164B | |
+9.96% | 154B | |
-8.02% | 140B |
- Stock Market
- Equities
- A5G Stock
- A5G Stock